期刊文献+

尼美舒利对Alzheimer's大鼠的脑保护作用 被引量:5

Neuroprotective effect of nimesulide on the brain of AD rats
下载PDF
导出
摘要 目的:建立大鼠Alzheimer's病(AD)炎症病理模型,探讨非甾体类抗炎药物尼美舒利在AD防治中的作用。方法:25只大鼠随机均分为β淀粉样蛋白(Aβ)组、Aβ+羧甲基纤维素钠组、Aβ+尼美舒利组、假手术组与空白对照组。前3组在大鼠双侧海马CA1区立体定向注射Aβ造AD模型,假手术组注射生理盐水,正常对照组不做任何处理。Aβ+尼美舒利组采用尼美舒利(2.5g/L)灌胃治疗,Aβ+羧甲基纤维素钠组给予50g/L羧甲基纤维素钠。4周后各组大鼠均作Y型迷宫测试观察学习记忆能力。采用免疫组化法检测大鼠脑组织胶质纤维酸性蛋白(GFAP)和Bcl2的表达。结果:与假手术组和空白对照组相比,Aβ组、Aβ+羧甲基纤维素钠组和Aβ+尼美舒利组学习记忆能力显著降低(P<0.05),GFAP及Bcl2阳性细胞数明显增加(P<0.05);与Aβ组及Aβ+羧甲基纤维素钠组相比,Aβ+尼美舒利组学习记忆能力显著改善,GFAP阳性细胞数明显降低,Bcl2阳性细胞数增加(P均<0.05)。结论:在体条件下尼美舒利通过抑制胶质细胞增生及细胞凋亡等机制对AD大鼠发挥脑保护作用。 Aim:To observe the therapeutic effects of nimesulide on Alzheimer's disease(AD) rats. Methods:A total of 25 rats were allocated into 5 groups: β-amyloid (Aβ) group, Aβ + sodium carboxymethylcelceulose (Aβ + SC ) group, Aβ + nimesulide group, sham-operation group and normal control group. The first 3 groups were given Aβ to induce AD model, and sham-operation group was given normal saline, then Aβ + SA group and Aβ + nimesulide group were given corresponding drugs, respectively. After 4 weeks the ablity of study and memory was detected by maze test. The expression of GFAP and Bcl-2 was detected using immunochemistry. Results: The nimesulide could ameliorate the ability of study and memory of AD. It could inhibit the hyperplasia of astrocytes and the cell apoptosis induced by Aβ. Conclusion: Nimesulide can improve the damage induced by Aβthrough restraining the hyperplasia of astrocytes and inhibiting the apoptosis of cells in hippocampi.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2006年第3期483-486,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关基金资助项目511040100
关键词 阿尔茨海默病 尼美舒利 学习记忆能力 胶质纤维酸性蛋白 BCL-2 大鼠 Alzheimer's disease nimesulide ability of study and memory GFAP Bcl-2 rat
  • 相关文献

参考文献11

  • 1Cummings JL,Cole G.Alzheimer disease.JAMA,2002,287(18):2 335
  • 2Sterit WJ,Conde JR,Harrison JK.Chemokines and Alzheimer's disease.Neurobiol Aging,2001,22 (6):909
  • 3Lue LF,Walker DG,Rogers J.Modeling microglial activation in Alzheimer's disease with human postmortern microglial cultures.Neurobiol Aging,2001,22 (6):945
  • 4Butterfield DA,Grriffin S,Munch G,et al.Amyloid betapeptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists.J Alzheimers Dis,2002,4(3):139
  • 5Griffin WS,Sheng JG,Roberts GW,et al.Interleukin-1 expression in different plaque types in Alzheimer's diseases:significance in plaque evolution.J Neuropatbol Exp Neurol,1995,54(2):276
  • 6Sheng JG,Mark RE,Griffin WS.Glial-neuronal interactions in Alzheimer's disease:progression association of IL-1 α + microglia and s1003 + astrocytes with neurofibrillory targle stages.J Neuropathol Exp Neurol,1997,56(3):285
  • 7Halliday G,Robinson SR,Shepherd C,et al.Alzheimer's disease and inflammation:a review of cellular and therapeutic mechanisms.Clin Exp Pharmacol Physiol,2000,27 (1-2):1
  • 8McGeer PL,Schulzer M,Mc Geer EG.Arthritis and antiinflammatory agents as possible protective factors for Alzheimer 's disease:a review of 17 epidemiologic studies.Neurology,1996,47(2):425
  • 9Wakita H,Tomimoto H,Akiguchi I,et al.Protective effect of cyclosporine A on whiter matter change in the rat brain after chronic cerebral hypoperfusion.Stroke,1995,26 (8):1 415
  • 10Wakita H,Tomimoto H,Akiguchi I.et al.A cyclooxygenase-2 inhibitor attenuates white matter damage in chronic cerebral ischemia.Neuroreport,1999,10 (7):1 461

同被引文献57

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部